Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 4/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.44 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.40 |
| ▸ | FAP | Q12884 | 1/20 | 0.38 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.38 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.38 |
| ▸ | APLNR | P35414 | 2/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 2/20 | 0.37 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | REN | P00797 | 3/20 | 0.36 |
| ▸ | STAT6 | P42226 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30697825 | 1.00 | ITGB3 (0.44) | ITGB3ITGA2BBDKRB2FAPNTSR2 | |
| SCHEMBL30697799 | 1.00 | ITGB3 (0.44) | ITGB3ITGA2BBDKRB2FAPNTSR2 | |
| SCHEMBL29816564 | 1.00 | ITGB3 (0.44) | ITGB3ITGA2BBDKRB2FAPNTSR2 | |
| SCHEMBL30697808 | 1.00 | ITGB3 (0.44) | ITGB3ITGA2BBDKRB2FAPNTSR2 | |
| SCHEMBL30697838 | 1.00 | ITGB3 (0.44) | ITGB3ITGA2BBDKRB2FAPNTSR2 | |
| SCHEMBL29816436 | 1.00 | ITGB3 (0.44) | ITGB3ITGA2BBDKRB2FAPNTSR2 | |
| SCHEMBL30697828 | 1.00 | ITGB3 (0.44) | ITGB3ITGA2BBDKRB2FAPNTSR2 | |
| SCHEMBL31135183 | 0.91 | ITGB3 (0.41) | ITGB3ITGA2BBDKRB2FAP | |
| SCHEMBL31135200 | 0.91 | ITGB3 (0.41) | ITGB3ITGA2BBDKRB2FAP | |
| SCHEMBL31135186 | 0.91 | ITGB3 (0.41) | ITGB3ITGA2BBDKRB2FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543480-A2 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF | Sustain Holdings, LLC (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-119698289-A | Pharmaceutical composition based on collagen peptide and application thereof | 莎思坦控股有限责任公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-118750586-A | Collagen-based pharmaceutical compositions and devices and methods of manufacture and use thereof | 莎思坦控股有限责任公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-118750585-A | Collagen-based pharmaceutical compositions and devices and methods of manufacture and use thereof | 莎思坦控股有限责任公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-118717953-A | Collagen-based pharmaceutical compositions and devices and methods of manufacture and use thereof | 莎思坦控股有限责任公司 | 2024-10-01 | — | — | CN | disclosed |
| US-20240016900-A1 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF | SUSTAIN HOLDINGS, LLC | 2024-01-18 | — | — | US | disclosed |
| WO-2024006771-A2 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF | SUSTAIN HOLDINGS, LLC (US) | 2024-01-04 | — | — | WO | disclosed |